Bacteriophage therapeutics has emerged as one of the few potential beacons that represent possible solutions to the growing global crisis of antimicrobial resistance. Bringing science to the bedside (and vice versa) will maximize the potential of this compelling opportunity.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Phage Therapy for Nontuberculous Mycobacteria: Challenges and Opportunities
Pulmonary Therapy Open Access 30 December 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rohwer, F., Maughan, H., Youle, M. & Hisakawa, N. Life in Our Phage World: A Centennial Field Guide to the Earth’s Most Diverse Inhabitants (Wholon, 2014).
Summers, W. C. Bacteriophage 2, 130–133 (2012).
Wommack, K. E. & Colwell, R. R. Microbiol. Mol. Biol. Rev. 64, 69–71 (2000).
Locey, K. J. & Lennon, J. T. Proc. Natl Acad. Sci. USA 24, 5970–5975 (2016).
Twort, F. W. Lancet 186, 1241–1243 (1915).
Fabijan, A. P. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-019-0634-z (2020).
Doogue, M. P. & Polasek, T. M. Ther. Adv. Drug Saf. 4, 5–7 (2013).
Ramratnam, B. et al. Nat. Med. 6, 82–85 (2000).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R. T. S. serves as a consultant to CytoDyn and has stock options in CytoDyn and Antiva Biosciences. He is a member of the Gilead Sciences Scientific Advisory Board and previously served as an uncompensated member of the AmpliPhi Scientific Advisory Board. S. S. holds stock in Adaptive Phage Therapeutics and is an uncompensated scientific advisor to NextBiotics.
Rights and permissions
About this article
Cite this article
Schooley, R.T., Strathdee, S. Treat phage like living antibiotics. Nat Microbiol 5, 391–392 (2020). https://doi.org/10.1038/s41564-019-0666-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-019-0666-4
This article is cited by
-
Phage Therapy for Nontuberculous Mycobacteria: Challenges and Opportunities
Pulmonary Therapy (2023)